Ask the experts: the potential of tyrosine kinase inhibitors in oncology

14 Apr 2022

Ask the Experts For clinicians For researchers Opinion Personalized and precision medicine Targeted therapies

In this ‘Ask the Experts’ feature, we spoke to a panel of experts working throughout the field of oncology to gain an insight into their current perspectives on the challenges and benefits of tyrosine kinase inhibitors (TKI's). We discuss the role that tyrosine kinases play in tumor biology, if there are factors that affect TKI selection for patients, what the side effects are and how our experts believe TKIs will develop over the next 5 years. Discover more about this topic from our experts: Justin Taylor (Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine; FL, USA), Skye...